{
  "citations": [
    {
      "id": 7283333,
      "title": "Pharmacogenetics: from bench to byte--an update of guidelines.",
      "_sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/21412232",
      "authors": [
        "Swen J J",
        "Nijenhuis M",
        "de Boer A",
        "Grandia L",
        "Maitland-van der Zee A H",
        "Mulder H",
        "Rongen G A P J M",
        "van Schaik R H N",
        "Schalekamp T",
        "Touw D J",
        "van der Weide J",
        "Wilffert B",
        "Deneer V H M",
        "Guchelaar H-J"
      ],
      "crossReferences": [
        {
          "id": 769250885,
          "resource": "PubMed",
          "resourceId": "21412232",
          "_url": "https://www.ncbi.nlm.nih.gov/pubmed/21412232",
          "version": 0
        },
        {
          "id": 1449247827,
          "resource": "DOI",
          "resourceId": "10.1038/clpt.2011.34",
          "_url": "http://dx.doi.org/10.1038%2Fclpt.2011.34",
          "version": 0
        }
      ],
      "hasKeyword": true,
      "journal": "Clinical pharmacology and therapeutics",
      "meshDiseases": [],
      "meshTerms": [
        "Animals",
        "Aryl Hydrocarbon Hydroxylases",
        "Cytochrome P-450 CYP2C9",
        "Drug Administration Schedule",
        "Drug-Related Side Effects and Adverse Reactions",
        "Humans",
        "Pharmaceutical Preparations",
        "Pharmacogenetics",
        "Practice Guidelines as Topic"
      ],
      "month": 5,
      "nonHuman": false,
      "objCls": "Literature",
      "page": "662-73",
      "pediatric": false,
      "pgkbPublication": false,
      "pubDate": "2011-05-01T00:00:00-07:00",
      "summary": "Currently, there are very few guidelines linking the results of pharmacogenetic tests to specific therapeutic recommendations. Therefore, the Royal Dutch Association for the Advancement of Pharmacy established the Pharmacogenetics Working Group with the objective of developing pharmacogenetics-based therapeutic (dose) recommendations. After systematic review of the literature, recommendations were developed for 53 drugs associated with genes coding for CYP2D6, CYP2C19, CYP2C9, thiopurine-S-methyltransferase (TPMT), dihydropyrimidine dehydrogenase (DPD), vitamin K epoxide reductase (VKORC1), uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1), HLA-B44, HLA-B*5701, CYP3A5, and factor V Leiden (FVL).",
      "terms": [],
      "version": 2,
      "volume": "89",
      "year": 2011
    }
  ],
  "guideline": {
    "objCls": "Guideline Annotation",
    "id": "PA166104964",
    "name": "Annotation of DPWG Guideline for clomipramine and CYP2D6",
    "alternateDrugAvailable": false,
    "cancerGenome": false,
    "crossReferences": [],
    "dosingInformation": false,
    "guidelineGenes": [
      {
        "id": 1451418286,
        "alleles": [
          {
            "id": 1451418287,
            "_label": "*1",
            "function": {
              "id": 1445558335,
              "parents": [],
              "resource": "Allele Function",
              "term": "Normal function",
              "termId": "haplotypeTags:1445558335",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165816576",
              "symbol": "CYP2D6*1",
              "name": "*1",
              "version": 43
            },
            "version": 0
          },
          {
            "id": 1451418340,
            "_label": "*1x2",
            "function": {
              "id": 1451309754,
              "description": "CYP2D6 function",
              "parents": [],
              "resource": "Allele Function",
              "term": "Increased function (AV 2)",
              "termId": "alleleFunction:1451309754",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA166228081",
              "symbol": "CYP2D6*1x2",
              "name": "*1x2",
              "version": 1
            },
            "version": 0
          },
          {
            "id": 1451418341,
            "_label": "*1x≥3",
            "function": {
              "id": 1451309780,
              "description": "CYP2D6 function",
              "parents": [],
              "resource": "Allele Function",
              "term": "Increased function (AV ≥3)",
              "termId": "alleleFunction:1451309780",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA166228141",
              "symbol": "CYP2D6*1x≥3",
              "name": "*1x≥3",
              "version": 1
            },
            "version": 0
          },
          {
            "id": 1451418288,
            "_label": "*2",
            "function": {
              "id": 1445558335,
              "parents": [],
              "resource": "Allele Function",
              "term": "Normal function",
              "termId": "haplotypeTags:1445558335",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165816577",
              "symbol": "CYP2D6*2",
              "name": "*2",
              "version": 42
            },
            "version": 0
          },
          {
            "id": 1451418342,
            "_label": "*2x2",
            "function": {
              "id": 1451309754,
              "description": "CYP2D6 function",
              "parents": [],
              "resource": "Allele Function",
              "term": "Increased function (AV 2)",
              "termId": "alleleFunction:1451309754",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA166228161",
              "symbol": "CYP2D6*2x2",
              "name": "*2x2",
              "version": 1
            },
            "version": 0
          },
          {
            "id": 1451418343,
            "_label": "*2x≥3",
            "function": {
              "id": 1451309780,
              "description": "CYP2D6 function",
              "parents": [],
              "resource": "Allele Function",
              "term": "Increased function (AV ≥3)",
              "termId": "alleleFunction:1451309780",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA166228162",
              "symbol": "CYP2D6*2x≥3",
              "name": "*2x≥3",
              "version": 1
            },
            "version": 0
          },
          {
            "id": 1451418289,
            "_label": "*3",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165816578",
              "symbol": "CYP2D6*3",
              "name": "*3",
              "version": 42
            },
            "version": 0
          },
          {
            "id": 1451418344,
            "_label": "*3x2",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA166228163",
              "symbol": "CYP2D6*3x2",
              "name": "*3x2",
              "version": 1
            },
            "version": 0
          },
          {
            "id": 1451418290,
            "_label": "*4",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165816579",
              "symbol": "CYP2D6*4",
              "name": "*4",
              "version": 42
            },
            "version": 0
          },
          {
            "id": 1451418348,
            "_label": "*4x2",
            "allele": "*4x2",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "version": 0
          },
          {
            "id": 1451418291,
            "_label": "*5",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165948092",
              "symbol": "CYP2D6*5",
              "name": "*5",
              "version": 41
            },
            "version": 0
          },
          {
            "id": 1451418292,
            "_label": "*6",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165816581",
              "symbol": "CYP2D6*6",
              "name": "*6",
              "version": 42
            },
            "version": 0
          },
          {
            "id": 1451418345,
            "_label": "*6x2",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA166228165",
              "symbol": "CYP2D6*6x2",
              "name": "*6x2",
              "version": 1
            },
            "version": 0
          },
          {
            "id": 1451418293,
            "_label": "*7",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165971559",
              "symbol": "CYP2D6*7",
              "name": "*7",
              "version": 39
            },
            "version": 0
          },
          {
            "id": 1451418294,
            "_label": "*8",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165971560",
              "symbol": "CYP2D6*8",
              "name": "*8",
              "version": 39
            },
            "version": 0
          },
          {
            "id": 1451418295,
            "_label": "*9",
            "function": {
              "id": 1445558331,
              "parents": [],
              "resource": "Allele Function",
              "term": "Decreased function",
              "termId": "haplotypeTags:1445558331",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165948317",
              "symbol": "CYP2D6*9",
              "name": "*9",
              "version": 41
            },
            "version": 0
          },
          {
            "id": 1451418296,
            "_label": "*9x2",
            "function": {
              "id": 1445558335,
              "parents": [],
              "resource": "Allele Function",
              "term": "Normal function",
              "termId": "haplotypeTags:1445558335",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA166123309",
              "symbol": "CYP2D6*9x2",
              "name": "*9x2",
              "version": 21
            },
            "version": 0
          },
          {
            "id": 1451418349,
            "_label": "*10",
            "allele": "*10",
            "function": {
              "id": 1445558331,
              "parents": [],
              "resource": "Allele Function",
              "term": "Decreased function",
              "termId": "haplotypeTags:1445558331",
              "version": 1
            },
            "version": 0
          },
          {
            "id": 1451418350,
            "_label": "*10x2",
            "allele": "*10x2",
            "function": {
              "id": 1445558335,
              "parents": [],
              "resource": "Allele Function",
              "term": "Normal function",
              "termId": "haplotypeTags:1445558335",
              "version": 1
            },
            "version": 0
          },
          {
            "id": 1451418297,
            "_label": "*11",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165971564",
              "symbol": "CYP2D6*11",
              "name": "*11",
              "version": 39
            },
            "version": 0
          },
          {
            "id": 1451418298,
            "_label": "*12",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165971565",
              "symbol": "CYP2D6*12",
              "name": "*12",
              "version": 39
            },
            "version": 0
          },
          {
            "id": 1451418299,
            "_label": "*13",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165988481",
              "symbol": "CYP2D6*13",
              "name": "*13",
              "version": 37
            },
            "version": 0
          },
          {
            "id": 1451418320,
            "_label": "*14",
            "function": {
              "id": 1445558331,
              "parents": [],
              "resource": "Allele Function",
              "term": "Decreased function",
              "termId": "haplotypeTags:1445558331",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA166181185",
              "symbol": "CYP2D6*14",
              "name": "*14",
              "version": 15
            },
            "version": 0
          },
          {
            "id": 1451418321,
            "_label": "*15",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165971568",
              "symbol": "CYP2D6*15",
              "name": "*15",
              "version": 39
            },
            "version": 0
          },
          {
            "id": 1451418322,
            "_label": "*17",
            "function": {
              "id": 1445558331,
              "parents": [],
              "resource": "Allele Function",
              "term": "Decreased function",
              "termId": "haplotypeTags:1445558331",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165816583",
              "symbol": "CYP2D6*17",
              "name": "*17",
              "version": 42
            },
            "version": 0
          },
          {
            "id": 1451418323,
            "_label": "*17x2",
            "function": {
              "id": 1445558335,
              "parents": [],
              "resource": "Allele Function",
              "term": "Normal function",
              "termId": "haplotypeTags:1445558335",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA166123457",
              "symbol": "CYP2D6*17x2",
              "name": "*17x2",
              "version": 21
            },
            "version": 0
          },
          {
            "id": 1451418324,
            "_label": "*18",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165971569",
              "symbol": "CYP2D6*18",
              "name": "*18",
              "version": 39
            },
            "version": 0
          },
          {
            "id": 1451418325,
            "_label": "*19",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165971570",
              "symbol": "CYP2D6*19",
              "name": "*19",
              "version": 39
            },
            "version": 0
          },
          {
            "id": 1451418326,
            "_label": "*20",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165971571",
              "symbol": "CYP2D6*20",
              "name": "*20",
              "version": 39
            },
            "version": 0
          },
          {
            "id": 1451418327,
            "_label": "*21",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165988484",
              "symbol": "CYP2D6*21",
              "name": "*21",
              "version": 38
            },
            "version": 0
          },
          {
            "id": 1451418328,
            "_label": "*29",
            "function": {
              "id": 1445558331,
              "parents": [],
              "resource": "Allele Function",
              "term": "Decreased function",
              "termId": "haplotypeTags:1445558331",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165948318",
              "symbol": "CYP2D6*29",
              "name": "*29",
              "version": 41
            },
            "version": 0
          },
          {
            "id": 1451418329,
            "_label": "*29x2",
            "function": {
              "id": 1445558335,
              "parents": [],
              "resource": "Allele Function",
              "term": "Normal function",
              "termId": "haplotypeTags:1445558335",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA166128735",
              "symbol": "CYP2D6*29x2",
              "name": "*29x2",
              "version": 14
            },
            "version": 0
          },
          {
            "id": 1451418330,
            "_label": "*31",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165971582",
              "symbol": "CYP2D6*31",
              "name": "*31",
              "version": 39
            },
            "version": 0
          },
          {
            "id": 1451418331,
            "_label": "*33",
            "function": {
              "id": 1445558335,
              "parents": [],
              "resource": "Allele Function",
              "term": "Normal function",
              "termId": "haplotypeTags:1445558335",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165971584",
              "symbol": "CYP2D6*33",
              "name": "*33",
              "version": 39
            },
            "version": 0
          },
          {
            "id": 1451418332,
            "_label": "*35",
            "function": {
              "id": 1445558335,
              "parents": [],
              "resource": "Allele Function",
              "term": "Normal function",
              "termId": "haplotypeTags:1445558335",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165988487",
              "symbol": "CYP2D6*35",
              "name": "*35",
              "version": 38
            },
            "version": 0
          },
          {
            "id": 1451418346,
            "_label": "*35x2",
            "function": {
              "id": 1451309754,
              "description": "CYP2D6 function",
              "parents": [],
              "resource": "Allele Function",
              "term": "Increased function (AV 2)",
              "termId": "alleleFunction:1451309754",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA166228166",
              "symbol": "CYP2D6*35x2",
              "name": "*35x2",
              "version": 1
            },
            "version": 0
          },
          {
            "id": 1451418333,
            "_label": "*36",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165988488",
              "symbol": "CYP2D6*36",
              "name": "*36",
              "version": 38
            },
            "version": 0
          },
          {
            "id": 1451418347,
            "_label": "*36x2",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA166228167",
              "symbol": "CYP2D6*36x2",
              "name": "*36x2",
              "version": 1
            },
            "version": 0
          },
          {
            "id": 1451418334,
            "_label": "*38",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165971592",
              "symbol": "CYP2D6*38",
              "name": "*38",
              "version": 39
            },
            "version": 0
          },
          {
            "id": 1451418335,
            "_label": "*39",
            "function": {
              "id": 1445558335,
              "parents": [],
              "resource": "Allele Function",
              "term": "Normal function",
              "termId": "haplotypeTags:1445558335",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA166001447",
              "symbol": "CYP2D6*39",
              "name": "*39",
              "version": 38
            },
            "version": 0
          },
          {
            "id": 1451418336,
            "_label": "*40",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165971594",
              "symbol": "CYP2D6*40",
              "name": "*40",
              "version": 39
            },
            "version": 0
          },
          {
            "id": 1451418337,
            "_label": "*41",
            "function": {
              "id": 1445558331,
              "parents": [],
              "resource": "Allele Function",
              "term": "Decreased function",
              "termId": "haplotypeTags:1445558331",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165816584",
              "symbol": "CYP2D6*41",
              "name": "*41",
              "version": 42
            },
            "version": 0
          },
          {
            "id": 1451418351,
            "_label": "*41x2",
            "function": {
              "id": 1445558335,
              "parents": [],
              "resource": "Allele Function",
              "term": "Normal function",
              "termId": "haplotypeTags:1445558335",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA166128209",
              "symbol": "CYP2D6*41x2",
              "name": "*41x2",
              "version": 15
            },
            "version": 0
          },
          {
            "id": 1451418338,
            "_label": "*42",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165971595",
              "symbol": "CYP2D6*42",
              "name": "*42",
              "version": 39
            },
            "version": 0
          },
          {
            "id": 1451418339,
            "_label": "*114",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA166181184",
              "symbol": "CYP2D6*114",
              "name": "*114",
              "version": 15
            },
            "version": 0
          }
        ],
        "gene": {
          "objCls": "Gene",
          "id": "PA128",
          "symbol": "CYP2D6",
          "name": "cytochrome P450 family 2 subfamily D member 6",
          "alleleFile": "CYP2D6_allele_definition_table.xlsx",
          "altNames": {
            "synonym": [
              "cytochrome P450, family 2, subfamily D, polypeptide 6"
            ],
            "symbol": [
              "CPD6",
              "CYP2D",
              "CYP2D7AP",
              "CYP2D7BP",
              "CYP2D7P2",
              "CYP2D8P2",
              "CYP2DL1",
              "P450-DB1",
              "P450C2D"
            ]
          },
          "buildVersion": "GRCh38.p7",
          "cbStart": "q13.1",
          "cbStop": "q13.2",
          "chr": {
            "objCls": "Chromosome",
            "id": "PA525",
            "name": "chr22",
            "version": 3
          },
          "chrStartPosB37": 42522501,
          "chrStartPosB38": 42125531,
          "chrStopPosB37": 42526883,
          "chrStopPosB38": 42130881,
          "cpicGene": true,
          "crossReferences": [
            {
              "id": 553242505,
              "resource": "Comparative Toxicogenomics Database",
              "resourceId": "1565",
              "_url": "http://ctdbase.org/detail.go?type=gene&acc=1565",
              "version": 0
            },
            {
              "id": 132256032,
              "resource": "Ensembl",
              "resourceId": "ENSG00000100197",
              "_url": "https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000100197",
              "version": 0
            },
            {
              "id": 73375,
              "resource": "GenAtlas",
              "resourceId": "CYP2D6",
              "_url": "http://genatlas.medecine.univ-paris5.fr/fiche.php?symbol=CYP2D6",
              "version": 1
            },
            {
              "id": 1445332056,
              "resource": "GenBank",
              "resourceId": "AY545216.1",
              "_url": "https://www.ncbi.nlm.nih.gov/nuccore/AY545216.1",
              "version": 0
            },
            {
              "id": 88303,
              "resource": "GeneCard",
              "resourceId": "CYP2D6",
              "_url": "https://www.genecards.org/cgi-bin/carddisp.pl?gene=CYP2D6",
              "version": 1
            },
            {
              "id": 605873023,
              "resource": "HGNC",
              "resourceId": "HGNC:2625",
              "_url": "https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC%3A2625",
              "version": 1
            },
            {
              "id": 605873080,
              "resource": "HumanCyc Gene",
              "resourceId": "HS01997",
              "_url": "http://biocyc.org/HUMAN/NEW-IMAGE?object=HS01997",
              "version": 0
            },
            {
              "id": 560877840,
              "resource": "ModBase",
              "resourceId": "P10635",
              "_url": "http://salilab.org/modbase/search?modelflag=longest&databaseID=P10635",
              "version": 0
            },
            {
              "id": 455913,
              "resource": "MutDB",
              "resourceId": "CYP2D6",
              "_url": "http://www.mutdb.org/genes/search?_method=POST&data%5BSearch%5D%5Bidentifier%5D=CYP2D6",
              "version": 1
            },
            {
              "id": 10749,
              "resource": "NCBI Gene",
              "resourceId": "1565",
              "_url": "https://www.ncbi.nlm.nih.gov/gene/1565",
              "version": 1
            },
            {
              "id": 717,
              "resource": "OMIM",
              "resourceId": "124030",
              "_url": "https://omim.org/entry/124030",
              "version": 1
            },
            {
              "id": 560556323,
              "resource": "OMIM",
              "resourceId": "608902",
              "_url": "https://omim.org/entry/608902",
              "version": 0
            },
            {
              "id": 1451280333,
              "resource": "PharmVar Gene",
              "resourceId": "CYP2D6",
              "_url": "https://www.pharmvar.org/gene/CYP2D6",
              "version": 0
            },
            {
              "id": 1451167850,
              "name": "NG_008376.4",
              "resource": "RefSeq DNA",
              "resourceId": "NG_008376.4",
              "_url": "https://www.ncbi.nlm.nih.gov/nuccore/NG_008376.4",
              "version": 0
            },
            {
              "id": 37278,
              "resource": "RefSeq Protein",
              "resourceId": "NP_000097",
              "_url": "https://www.ncbi.nlm.nih.gov/nuccore/NP_000097",
              "version": 1
            },
            {
              "id": 123170196,
              "resource": "RefSeq Protein",
              "resourceId": "NP_001020332",
              "_url": "https://www.ncbi.nlm.nih.gov/nuccore/NP_001020332",
              "version": 1
            },
            {
              "id": 46353,
              "resource": "RefSeq RNA",
              "resourceId": "NM_000106",
              "_url": "https://www.ncbi.nlm.nih.gov/nuccore/NM_000106",
              "version": 1
            },
            {
              "id": 123170193,
              "resource": "RefSeq RNA",
              "resourceId": "NM_001025161",
              "_url": "https://www.ncbi.nlm.nih.gov/nuccore/NM_001025161",
              "version": 1
            },
            {
              "id": 121670,
              "resource": "UCSC Genome Browser",
              "resourceId": "NM_000106",
              "_url": "https://genome.ucsc.edu/cgi-bin/hgTracks?Submit=Submit&position=NM_000106",
              "version": 1
            },
            {
              "id": 605873078,
              "name": "Q6NWU0_HUMAN",
              "resource": "UniProtKB",
              "resourceId": "Q6NWU0",
              "_url": "https://www.uniprot.org/uniprot/Q6NWU0",
              "version": 1
            },
            {
              "id": 605873076,
              "name": "Q6NXU8_HUMAN",
              "resource": "UniProtKB",
              "resourceId": "Q6NXU8",
              "_url": "https://www.uniprot.org/uniprot/Q6NXU8",
              "version": 1
            }
          ],
          "hasNonStandardHaplotypes": false,
          "hideHaplotypes": false,
          "pharmVarGene": true,
          "strand": "minus",
          "terms": [
            {"id":560498878,"_url":"http://amigo.geneontology.org/amigo/term/GO:0004497","resource":"Gene Ontology","term":"monooxygenase activity","termId":"GO:0004497"},
            {"id":560500079,"_url":"http://amigo.geneontology.org/amigo/term/GO:0005739","resource":"Gene Ontology","term":"mitochondrion","termId":"GO:0005739"},
            {"id":560500134,"_url":"http://amigo.geneontology.org/amigo/term/GO:0005783","resource":"Gene Ontology","term":"endoplasmic reticulum","termId":"GO:0005783"},
            {"id":560500141,"_url":"http://amigo.geneontology.org/amigo/term/GO:0005789","resource":"Gene Ontology","term":"endoplasmic reticulum membrane","termId":"GO:0005789"},
            {"id":560500144,"_url":"http://amigo.geneontology.org/amigo/term/GO:0005792","resource":"Gene Ontology","term":"microsome","termId":"GO:0005792"},
            {"id":560501453,"_url":"http://amigo.geneontology.org/amigo/term/GO:0006805","resource":"Gene Ontology","term":"xenobiotic metabolic process","termId":"GO:0006805"},
            {"id":560499864,"_url":"http://amigo.geneontology.org/amigo/term/GO:0008144","resource":"Gene Ontology","term":"drug binding","termId":"GO:0008144"},
            {"id":560501294,"_url":"http://amigo.geneontology.org/amigo/term/GO:0008202","resource":"Gene Ontology","term":"steroid metabolic process","termId":"GO:0008202"},
            {"id":560503412,"_url":"http://amigo.geneontology.org/amigo/term/GO:0009055","resource":"Gene Ontology","term":"electron carrier activity","termId":"GO:0009055"},
            {"id":560504161,"_url":"http://amigo.geneontology.org/amigo/term/GO:0009804","resource":"Gene Ontology","term":"coumarin metabolic process","termId":"GO:0009804"},
            {"id":560504179,"_url":"http://amigo.geneontology.org/amigo/term/GO:0009820","resource":"Gene Ontology","term":"alkaloid metabolic process","termId":"GO:0009820"},
            {"id":560504180,"_url":"http://amigo.geneontology.org/amigo/term/GO:0009822","resource":"Gene Ontology","term":"alkaloid catabolic process","termId":"GO:0009822"},
            {"id":560504242,"_url":"http://amigo.geneontology.org/amigo/term/GO:0009892","resource":"Gene Ontology","term":"negative regulation of metabolic process","termId":"GO:0009892"},
            {"id":560499972,"_url":"http://amigo.geneontology.org/amigo/term/GO:0016020","resource":"Gene Ontology","term":"membrane","termId":"GO:0016020"},
            {"id":560506711,"_url":"http://amigo.geneontology.org/amigo/term/GO:0016098","resource":"Gene Ontology","term":"monoterpenoid metabolic process","termId":"GO:0016098"},
            {"id":560495264,"_url":"http://amigo.geneontology.org/amigo/term/GO:0016491","resource":"Gene Ontology","term":"oxidoreductase activity","termId":"GO:0016491"},
            {"id":560507281,"_url":"http://amigo.geneontology.org/amigo/term/GO:0017144","resource":"Gene Ontology","term":"drug metabolic process","termId":"GO:0017144"},
            {"id":560509358,"_url":"http://amigo.geneontology.org/amigo/term/GO:0020037","resource":"Gene Ontology","term":"heme binding","termId":"GO:0020037"},
            {"id":560512928,"_url":"http://amigo.geneontology.org/amigo/term/GO:0033076","resource":"Gene Ontology","term":"isoquinoline alkaloid metabolic process","termId":"GO:0033076"},
            {"id":560515689,"_url":"http://amigo.geneontology.org/amigo/term/GO:0042737","resource":"Gene Ontology","term":"drug catabolic process","termId":"GO:0042737"},
            {"id":560495388,"_url":"http://amigo.geneontology.org/amigo/term/GO:0046483","resource":"Gene Ontology","term":"heterocycle metabolic process","termId":"GO:0046483"},
            {"id":560495445,"_url":"http://amigo.geneontology.org/amigo/term/GO:0046872","resource":"Gene Ontology","term":"metal ion binding","termId":"GO:0046872"},
            {"id":560511965,"_url":"http://amigo.geneontology.org/amigo/term/GO:0051100","resource":"Gene Ontology","term":"negative regulation of binding","termId":"GO:0051100"},
            {"id":560509993,"_url":"http://amigo.geneontology.org/amigo/term/GO:0055114","resource":"Gene Ontology","term":"oxidation reduction","termId":"GO:0055114"},
            {"id":560523003,"_url":"http://amigo.geneontology.org/amigo/term/GO:0070330","resource":"Gene Ontology","term":"aromatase activity","termId":"GO:0070330"}
          ],
          "version": 7890
        },
        "version": 0
      }
    ],
    "hasTestingInfo": true,
    "history": [
      {
        "id": 1183704455,
        "date": "2011-08-10T00:00:00-07:00",
        "type": "Create",
        "version": 0
      },
      {
        "id": 1450415092,
        "date": "2019-05-23T20:29:59.032-07:00",
        "description": "Annotation current with November 2018 DPWG Guideline release",
        "type": "Update",
        "version": 0
      },
      {
        "id": 1450820778,
        "date": "2019-10-06T22:31:16.519-07:00",
        "description": "August 2019 Guideline update",
        "type": "Update",
        "version": 0
      },
      {
        "id": 1450956300,
        "date": "2020-01-31T13:22:12.315-08:00",
        "description": "Updated link to 2011 DPWG methods",
        "type": "Update",
        "version": 0
      },
      {
        "id": 1450962742,
        "date": "2020-02-10T10:49:01.846-08:00",
        "description": "Fixed links to 2019 guideline pdfs. 2018 link already went to attachment.",
        "type": "Update",
        "version": 0
      },
      {
        "id": 1451109120,
        "date": "2020-04-14T00:00:00-07:00",
        "description": "Corrected description and recommendation for CYP2D6 UMs",
        "type": "Update",
        "version": 0
      },
      {
        "id": 1451431304,
        "date": "2021-05-04T00:00:00-07:00",
        "description": "Added extended dosing",
        "type": "Update",
        "version": 0
      },
      {
        "id": 1451704208,
        "date": "2022-03-03T16:33:27.785-08:00",
        "description": "Annotation current with May 2021 DPWG Guideline release",
        "type": "Note",
        "version": 0
      },
      {
        "id": 1451706260,
        "date": "2022-03-07T15:55:03.676-08:00",
        "description": "Added information about preemptive genotyping",
        "type": "Update",
        "version": 0
      },
      {
        "id": 1451732848,
        "date": "2022-03-28T09:57:41.440-07:00",
        "description": "Annotation current with February 2022 DPWG guideline release",
        "type": "Note",
        "version": 0
      },
      {
        "id": 1451733302,
        "date": "2022-03-28T14:35:55.031-07:00",
        "description": "Updated link to testing guidance page",
        "type": "Update",
        "version": 0
      },
      {
        "id": 1451741471,
        "date": "2022-04-05T11:12:05.345-07:00",
        "description": "Added testing guidance tag",
        "type": "Update",
        "version": 0
      },
      {
        "id": 1451884160,
        "date": "2022-09-16T09:54:56.272-07:00",
        "description": "Fixed link to gene information document and added explanatory note",
        "type": "Update",
        "version": 0
      }
    ],
    "literature": [
      {"id":7283333,"title":"Pharmacogenetics: from bench to byte--an update of guidelines.","_sameAs":"https://www.ncbi.nlm.nih.gov/pubmed/21412232","crossReferences":[{"id":769250885,"resource":"PubMed","resourceId":"21412232","_url":"https://www.ncbi.nlm.nih.gov/pubmed/21412232"},{"id":1449247827,"resource":"DOI","resourceId":"10.1038/clpt.2011.34","_url":"http://dx.doi.org/10.1038%2Fclpt.2011.34"}],"objCls":"Literature","terms":[]},
      {"id":15103288,"title":"Dutch Pharmacogenetics Working Group Guidelines August 2019","_sameAs":"https://api.pharmgkb.org/v1/preview/download/file/attachment/DPWG_August_2019.pdf","crossReferences":[{"id":1450815695,"resource":"URL","resourceId":"https://api.pharmgkb.org/v1/preview/download/file/attachment/DPWG_August_2019.pdf","_url":"https://api.pharmgkb.org/v1/preview/download/file/attachment/DPWG_August_2019.pdf"}],"objCls":"Literature","terms":[]},
      {"id":15102465,"title":"Dutch Pharmacogenetics Working Group Guidelines November 2018","_sameAs":"https://api.pharmgkb.org/v1/preview/download/file/attachment/DPWG_November_2018.pdf","crossReferences":[{"id":1450415575,"resource":"URL","resourceId":"https://api.pharmgkb.org/v1/preview/download/file/attachment/DPWG_November_2018.pdf","_url":"https://api.pharmgkb.org/v1/preview/download/file/attachment/DPWG_November_2018.pdf"}],"objCls":"Literature","terms":[]}
    ],
    "pediatric": false,
    "recommendation": true,
    "relatedAlleles": [],
    "relatedChemicals": [
      {
        "objCls": "Chemical",
        "id": "PA449048",
        "name": "clomipramine",
        "version": 5
      }
    ],
    "relatedGenes": [
      {
        "objCls": "Gene",
        "id": "PA128",
        "symbol": "CYP2D6",
        "name": "cytochrome P450 family 2 subfamily D member 6",
        "version": 7890
      }
    ],
    "source": "DPWG",
    "summaryMarkdown": {
      "id": 1447981906,
      "html": "<p>The Dutch Pharmacogenetics Working Group Guideline for clomipramine recommends dose changes and to monitor the effect and side effects and the plasma concentrations to set the maintenance dose for CYP2D6 poor (PM), and intermediate (IM) metabolizer or to avoid clomipramine in PM and ultrarapid (UM) metabolizer.</p>\n",
      "version": 2
    },
    "terms": [],
    "textMarkdown": {
      "id": 1447981905,
      "html": "<h3 id=\"august-2019-update\">August 2019 Update</h3>\n<p><em><strong>IMPORTANT: As of March 2022, gene information documents from the DPWG are no longer publicly available from the KNMP website. PharmGKB is currently providing PDF versions of these documents to users. These files were downloaded in February 2022. As such, we cannot guarantee that these documents match the mappings DPWG may use internally as there have been no publicly accessible updates since February 2022.</strong></em></p>\n<p>The Royal Dutch Pharmacists Association - Pharmacogenetics Working Group has evaluated therapeutic dose recommendations for clomipramine based on CYP2D6 genotype. They recommend dose changes and to monitor the effect and side effects and the plasma concentrations to set the maintenance dose for CYP2D6 poor (PM), and intermediate (IM) metabolizer or to avoid clomipramine in PM and ultrarapid (UM) metabolizer.</p>\n<p><em>Wording in table taken from the <a download=\"DPWG_August_2019.pdf\" href=\"https://api.pharmgkb.org/v1/download/file/attachment/DPWG_August_2019.pdf\">Dutch guidelines August 2019 update</a></em></p>\n<table class=\"table\">\n<thead>\n<tr>\n<th>Allele/Genotype/Phenotype</th>\n<th>Drug</th>\n<th>Description</th>\n<th>Recommendation</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>CYP2D6 UM</td>\n<td>clomipramine</td>\n<td>The risk of ineffectiveness and cardiotoxic side effects may be increased. The gene variation leads to reduced plasma concentrations of clomipramine and the active metabolite desmethylclomipramine and to increased concentrations of the potentially cardiotoxic hydroxy metabolites.</td>\n<td>Use 1.5 times the standard dose and monitor the effect and side effects of the plasma concentrations of clomipramine and desmethylclomipramine to set the maintenance dose. For depression, the therapeutic range is 200-400 ng/mL for the sum of the plasma concentrations of clomipramine and desmethylclomipramine. For anxiety disorders, the therapeutic plasma concentration of clomipramine is approximately 100 ng/mL, in combination with a plasma concentration of desmethylclomipramine lower than 200 ng/mL. For obsessive compulsive disorder, the therapeutic plasma concentration of clomipramine is higher than 200 ng/mL, in combination with a plasma concentration of desmethylclomipramine that is as low as possible. If a dose increase is not wanted due to potential cardiotoxic hydroxy metabolites: avoid clomipramine. Antidepressants that are not metabolised by CYP2D6, or to a lesser extent, include citalopram and sertraline.</td>\n</tr>\n<tr>\n<td>CYP2D6 IM</td>\n<td>clomipramine</td>\n<td>The risk of side effects may be increased, because the gene variation leads to increased plasma concentrations of clomipramine and the active metabolite desmethylclomipramine.</td>\n<td>Use 70% of the standard dose and monitor the effect and side effects or the plasma concentrations of clomipramine and desmethylclomipramine. For depression, the therapeutic range is 200-400 ng/mL for the sum of the plasma concentrations of clomipramine and desmethylclomipramine. For anxiety disorders, the therapeutic plasma concentration of clomipramine is approximately 100 ng/mL, in combination with a plasma concentration of desmethylclomipramine lower than 200 ng/mLFor obsessive compulsive disorder, the therapeutic plasma concentration of clomipramine is higher than 200 ng/mL, in combination with a plasma concentration of desmethylclomipramine that is as low as possible. A sum of the plasma concentrations of clomipramine and desmethylclomipramine higher than 600 ng/mL is considered toxic.</td>\n</tr>\n<tr>\n<td>CYP2D6 PM</td>\n<td>clomipramine</td>\n<td>The risk of side effects may be increased, because the gene variation leads to increased plasma concentrations of clomipramine and the active metabolite desmethylclomipramine.</td>\n<td>Indication DEPRESSION: use 50% of the standard dose and monitor the effect and side effects or the plasma concentrations of clomipramine and desmethylclomipramine in order to set the maintenance dose. The therapeutic range is 200-400 ng/mL for the sum of the plasma concentrations of clomipramine and desmethylclomipramine. Values higher than 600 ng/mL are considered toxic. Indication ANXIETY DISORDERS or OBSESSIVE COMPULSIVE DISORDER: if side effects occur: use 50% of the standard dose and monitor the effect and side effects or the plasma concentrations of clomipramine and desmethylclomipramine in order to set the maintenance dose. It is not known whether it is possible to reduce the dose to such an extent that the side effects disappear while the effectiveness is retained. Clomipramine and desmethylclomipramine both contribute to the side effects. Only clomipramine contributes to the effectiveness. For anxiety disorders, the therapeutic plasma concentration of clomipramine is approximately 100 ng/mL, in combination with a plasma concentration of desmethylclomipramine lower than 200 ng/mL. For obsessive compulsive disorder, the therapeutic plasma concentration of clomipramine is higher than 200 ng/mL, in combination with a plasma concentration of desmethylclomipramine that is as low as possible. A sum of the plasma concentrations of clomipramine and desmethylclomipramine higher than 600 ng/mL is considered toxic, whilst the therapeutic upper limit for depression is 400 ng/mL. If dose reduction does not have the desired effect: avoid clomipramine. Antidepressants that are not metabolised by CYP2D6, or to a lesser extent, include citalopram and sertraline.</td>\n</tr>\n</tbody>\n</table>\n<h4 id=\"preemptive-genotyping\">Preemptive genotyping</h4>\n<p>Excerpts from the <a rel=\"noopener noreferrer\" href=\"https://www.g-standaard.nl/risicoanalyse/B0001481.PDF\" target=\"_blank\">DPWG risk analysis document</a> for clomipramine and CYP2D6:</p>\n<blockquote class=\"blockquote\">\n<p>The Dutch Pharmacogenetics Working Group considers genotyping before starting clomipramine to be potentially beneficial for the prevention of side effects and for drug efficacy. Genotyping can be considered on an individual patient basis. If, however, the genotype is available, the Dutch Pharmacogenetics Working Group recommends adhering to the gene-drug guideline.</p>\n</blockquote>\n<p><a href=\"/page/testingGuidance\">Read more about how DPWG assigns their recommendations for preemptive genotyping.</a></p>\n<p><a rel=\"noopener noreferrer\" href=\"https://www.g-standaard.nl/risicoanalyse/B0001480.PDF\" target=\"_blank\">Read for more information about this recommendation</a>, <a download=\"CYP2D6.pdf\" href=\"https://api.pharmgkb.org/v1/download/file/attachment/CYP2D6.pdf\">Read about gene information from DPWG</a></p>\n<h3 id=\"november-2018-update\">November 2018 Update</h3>\n<p>The Royal Dutch Pharmacists Association - Pharmacogenetics Working Group has evaluated therapeutic dose recommendations for clomipramine based on CYP2D6 genotype. They recommend dose changes and to monitor the effect and side effects and the plasma concentrations to set the maintenance dose for CYP2D6 poor (PM), intermediate (IM), and ultrarapid (UM) metabolizer or to avoid clomipramine in PM and UM.</p>\n<p><em>Wording in table taken from <a download=\"DPWG_November_2018.pdf\" href=\"https://api.pharmgkb.org/v1/download/file/attachment/DPWG_November_2018.pdf\">Dutch guidelines November 2018 update</a></em></p>\n<table class=\"table\">\n<thead>\n<tr>\n<th>Allele/Genotype/Phenotype</th>\n<th>Drug</th>\n<th>Description</th>\n<th>Recommendation</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>CYP2D6 UM</td>\n<td>clomipramine</td>\n<td>The risk of ineffectiveness and cardiotoxic side effects may be increased. The gene variation leads to reduced plasma concentrations of clomipramine and the active metabolite desmethylclomipramine and to increased concentrations of the potentially cardiotoxic hydroxy metabolites.</td>\n<td>Use 1.5 times the standard dose and monitor the effect and side effects of the plasma concentrations of clomipramine and desmethylclomipramine to set the maintenance dose. For depression, the therapeutic range is 200-400 ng/mL for the sum of the plasma concentrations of clomipramine and desmethylclomipramine. For anxiety disorders, the therapeutic plasma concentration of clomipramine is approximately 100 ng/mL, in combination with a plasma concentration of desmethylclomipramine lower than 200 ng/mL. For obsessive compulsive disorder, the therapeutic plasma concentration of clomipramine is higher than 200 ng/mL, in combination with a plasma concentration of desmethylclomipramine that is as low as possible. If a dose increase is not wanted due to potential cardiotoxic hydroxy metabolites: avoid clomipramine. Antidepressants that are not metabolised by CYP2D6, or to a lesser extent, include citalopram and sertraline.</td>\n</tr>\n<tr>\n<td>CYP2D6 IM</td>\n<td>clomipramine</td>\n<td>The risk of side effects may be increased, because the gene variation leads to increased plasma concentrations of clomipramine and the active metabolite desmethylclomipramine.</td>\n<td>Use 70% of the standard dose and monitor the effect and side effects or the plasma concentrations of clomipramine and desmethylclomipramine. For depression, the therapeutic range is 200-400 ng/mL for the sum of the plasma concentrations of clomipramine and desmethylclomipramine. For anxiety disorders, the therapeutic plasma concentration of clomipramine is approximately 100 ng/mL, in combination with a plasma concentration of desmethylclomipramine lower than 200 ng/mL. For obsessive compulsive disorder, the therapeutic plasma concentration of clomipramine is higher than 200 ng/mL, in combination with a plasma concentration of desmethylclomipramine that is as low as possible. A sum of the plasma concentrations of clomipramine and desmethylclomipramine higher than 600 ng/mL is considered toxic.</td>\n</tr>\n<tr>\n<td>CYP2D6 PM</td>\n<td>clomipramine</td>\n<td>The risk of side effects may be increased, because the gene variation leads to increased plasma concentrations of clomipramine and the active metabolite desmethylclomipramine.</td>\n<td>Indication DEPRESSION: use 50% of the standard dose and monitor the effect and side effects or the plasma concentrations of clomipramine and desmethylclomipramine in order to set the maintenance dose. The therapeutic range is 200-400 ng/mL for the sum of the plasma concentrations of clomipramine and desmethylclomipramine. Values higher than 600 ng/mL are considered toxic. Indication ANXIETY DISORDERS or OBSESSIVE COMPULSIVE DISORDER: if side effects occur: use 50% of the standard dose and monitor the effect and side effects or the plasma concentrations of clomipramine and desmethylclomipramine in order to set the maintenance dose. It is not known whether it is possible to reduce the dose to such an extent that the side effects disappear while the effectiveness is retained. Clomipramine and desmethylclomipramine both contribute to the side effects. Only clomipramine contributes to the effectiveness. For anxiety disorders, the therapeutic plasma concentration of clomipramine is approximately 100 ng/mL, in combination with a plasma concentration of desmethylclomipramine lower than 200 ng/mL. For obsessive compulsive disorder, the therapeutic plasma concentration of clomipramine is higher than 200 ng/mL, in combination with a plasma concentration of desmethylclomipramine that is as low as possible. A sum of the plasma concentrations of clomipramine and desmethylclomipramine higher than 600 ng/mL is considered toxic, whilst the therapeutic upper limit for depression is 400 ng/mL. If dose reduction does not have the desired effect: avoid clomipramine. Antidepressants that are not metabolised by CYP2D6, or to a lesser extent, include citalopram and sertraline.</td>\n</tr>\n</tbody>\n</table>\n<p><a rel=\"noopener noreferrer\" href=\"https://www.g-standaard.nl/risicoanalyse/B0001482.PDF\" target=\"_blank\">Read for more information about this recommendation</a>, <a rel=\"noopener noreferrer\" href=\"https://www.knmp.nl/producten/gebruiksrecht-g-standaard/medicatiebewaking-g-standaard/background-information-pharmacogenetics\" target=\"_blank\">Read about gene information from DPWG</a></p>\n<h3 id=\"2011-guideline\">2011 Guideline</h3>\n<p>The Royal Dutch Pharmacists Association - Pharmacogenetics Working Group has evaluated therapeutic dose recommendations for clomipramine based on CYP2D6 genotypes [Article:<a href=\"/pmid/21412232\">21412232</a>].  They recommend lower dose for patients carrying the poor metabolizer (PM) alleles and alternative drug for patients carrying the ultrarapid metabolizer (UM) allleles.</p>\n<table class=\"table\">\n<thead>\n<tr>\n<th>Phenotype (Genotype)</th>\n<th>Therapeutic Dose Recommendation</th>\n<th>Level of Evidence</th>\n<th>Clinical Relevance</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>PM (two inactive (*3-*8, *11-*16, *19-*21, *38, *40, *42) alleles)</td>\n<td>Reduce dose by 50% and monitor (desmethyl) clomipramine plasma concentration.</td>\n<td>Published controlled studies of good quality* relating to phenotyped and/or genotyped patients or healthy volunteers, and having relevant pharmacokinetic or clinical endpoints.</td>\n<td>Clinical effect (S): long-standing discomfort (48-168 hr) without permanent injury e.g. failure of therapy with tricyclic antidepressants, atypical antipsychotic drugs; extrapyramidal side effects; parkinsonism; ADE resulting from increased bioavailability of tricyclic antidepressants, metoprolol, propafenone (central effects e.g. dizziness); INR 4.5-6.0; neutropenia 1.0-1.5x10<sup>9</sup>/l; leucopenia 2.0-3.0x10<sup>9</sup>/l; thrombocytopenia 50-75x10<sup>9</sup>/l.</td>\n</tr>\n<tr>\n<td>IM (two decreased-activity (*9, *10, *17, *29, *36, *41) alleles or carrying one active (*1, *2, *33, *35) and one inactive (*3-*8, *11-*16, *19-*21, *38, *40, *42) allele, or carrying one decreased-activity (*9, *10, *17, *29, *36, *41) allele and one inactive (*3-*8, *11-*16, *19-*21, *38, *40, *42) allele)</td>\n<td>Insufficient data to allow calculation of dose adjustment. Monitor (desmethyl)clomipramine plasma concentration</td>\n<td>Published controlled studies of good quality* relating to phenotyped and/or genotyped patients or healthy volunteers, and having relevant pharmacokinetic or clinical endpoints.</td>\n<td>Clinical effect (S): long-standing discomfort (48-168 hr) without permanent injury e.g. failure of therapy with tricyclic antidepressants, atypical antipsychotic drugs; extrapyramidal side effects; parkinsonism; ADE resulting from increased bioavailability of tricyclic antidepressants, metoprolol, propafenone (central effects e.g. dizziness); INR 4.5-6.0; neutropenia 1.0-1.5x10<sup>9</sup>/l; leucopenia 2.0-3.0x10<sup>9</sup>/l; thrombocytopenia 50-75x10<sup>9</sup>/l.</td>\n</tr>\n<tr>\n<td>UM (a gene duplication in absence of inactive (*3-*8, *11-*16, *19-*21, *38, *40, *42) or decreased-activity (*9, *10, *17, *29, *36, *41) alleles)</td>\n<td>Select alternative drug (e.g., citalopram, sertralin) or monitor (desmethyl)clomipramine plasma concentration.</td>\n<td>Published case reports, well documented, and having relevant pharmacokinetic or clinical endpoints. Well documented case series.</td>\n<td>Clinical effect (S): long-standing discomfort (48-168 hr) without permanent injury e.g. failure of therapy with tricyclic antidepressants, atypical antipsychotic drugs; extrapyramidal side effects; parkinsonism; ADE resulting from increased bioavailability of tricyclic antidepressants, metoprolol, propafenone (central effects e.g. dizziness); INR 4.5-6.0; neutropenia 1.0-1.5x10<sup>9</sup>/l; leucopenia 2.0-3.0x10<sup>9</sup>/l; thrombocytopenia 50-75x10<sup>9</sup>/l.</td>\n</tr>\n</tbody>\n</table>\n<ul>\n<li>*See <a href=\"http://www.pharmgkb.org/page/dpwg\">Methods </a> or [Article:<a href=\"/pmid/18253145\">18253145</a>] for definition of &quot;good quality.&quot;</li>\n<li>S: statistically significant difference.</li>\n<li>Please see attached PDF for detailed information about the evaluated studies: <a download=\"clomipramine_CYP2D6_271111.pdf\" href=\"https://api.pharmgkb.org/v1/download/file/attachment/clomipramine_CYP2D6_271111.pdf\">Clomipramine CYP2D6</a></li>\n</ul>\n",
      "version": 16
    },
    "userId": "cfthorn",
    "version": 29
  }
}